An exploratory study of primary care pharmacist-led epilepsy consultations
- 18 May 2012
- journal article
- Published by Oxford University Press (OUP) in International Journal of Pharmacy Practice
- Vol. 20 (5), 294-302
- https://doi.org/10.1111/j.2042-7174.2012.00207.x
Abstract
Objective Most epilepsies are managed with anti-epileptic drugs (AEDs), but medication non-adherence has been frequently reported. Satisfying patient information needs has demonstrated improved adherence. Multi-professional working has been encouraged to provide cost-effective health services by using the most appropriate healthcare professional. Research has demonstrated that pharmacist-led consultations are acceptable to patients with other medical conditions and therefore may be appropriate for patients with epilepsy. We aimed to determine the feasibility and acceptability of a pharmacist-led epilepsy consultation (PLEC) study. This encompassed estimating the eligibility and consent rate for a PLEC study, plus the acceptability of potential intervention outcome measures and likely effects. Methods Eligible patients with a diagnosis of epilepsy and prescribed AEDs were invited by telephone to attend a PLEC. Baseline adherence, general mental well-being, epilepsy-related quality of life and satisfaction with information received about epilepsy medication were recorded. The intervention was a 30 min consultation to provide participants with an opportunity to ask questions related to their epilepsy therapy. Baseline data collection was repeated after 2 months. Results Of 106 (97.2%) consenting patients, 82 (77.4%) attended the PLEC. The 2 month follow-up questionnaire was fully completed by 50 (67.6%) participants. The number (percentage ± 95% confidence interval) of participants reporting adherent behaviour pre-PLEC was 22 (44.0 ± 13.7%) which increased to 30 (60 ± 13.6%) post-PLEC (P < 0.03, McNemar test). Discussion Accepting the limitations of a before-and-after study and small sample size, the findings suggest that a PLEC may improve adherence. A definitive trial is necessary to confirm the effect of a PLEC and establish the longevity and cost-effectiveness of the outcomes. Attrition of potential participants not contactable by telephone suggests the need for additional postal contact in subsequent trials. A reduction in loss to follow-up is also desirable and potentially achievable using telephone reminders.Keywords
This publication has 21 references indexed in Scilit:
- Pharmacist-led medication review clinics in general practice: the views of Greater Glasgow GPsInternational Journal of Pharmacy Practice, 2003
- Tuesday 16 SeptemberInternational Journal of Pharmacy Practice, 2003
- Self-regulation and Self-management in Asthma: Exploring The Role of Illness Perceptions and Treatment Beliefs in Explaining Non-adherence to Preventer MedicationPsychology & Health, 2002
- The Satisfaction with Information about Medicines Scale (SIMS): a new measurement tool for audit and researchQuality and Safety in Health Care, 2001
- Self-Management of EpilepsyDisease Management and Health Outcomes, 2000
- Dose Frequency and Dose Interval Compliance with Multiple Antiepileptic Medications During a Controlled Clinical TrialEpilepsia, 1995
- The initial development of a health-related quality of life model as an outcome measure in epilepsyEpilepsy Research, 1993
- Can simple clinical measurements detect patient noncompliance?Hypertension, 1980
- A scaled version of the General Health QuestionnairePsychological Medicine, 1979
- A Comparison of Two Psychiatric Screening TestsThe British Journal of Psychiatry, 1976